Podcast

Implementing a Shingles Protocol in Specialty Practices

Launch Date
09/18/2020
Credit Amount
0.00 Expired
Credit Expires
09/18/2021

Faculty

William Schaffner, MD
Professor of Preventive Medicine, Department of Health Policy
Professor of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN
William Schaffner, MD

Dr. William Schaffner is Professor of Preventive Medicine in the Department of Health Policy and Professor of Infectious Diseases at the Vanderbilt University School of Medicine, Nashville, Tennessee.

Dr. Schaffner’s primary focus has been the prevention of infectious diseases. He is a strong proponent of collaboration between academic medical centers and public health institutions. He has worked extensively on the effective use of vaccines and has been a member of expert advisory committees that establish national vaccine policy.

Dr. Schaffner is committed to the communication of disease prevention with the general public and regards this as a teaching opportunity. He is often invited to comment on communicable disease issues on local and national media, translating research and public health events into language that the public can understand.

After graduating from Yale in 1957, Schaffner attended the University of Freiburg, Germany as a Fulbright Scholar. He graduated from Cornell University Medical College in 1962 and completed residency training and a Fellowship in Infectious Diseases at Vanderbilt. He was commissioned in the U.S. Public Health Service as an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention (CDC) for two years. He returned to Vanderbilt after that tour of duty and established a long collaboration with the Tennessee Department of Health and the CDC.

Paul G. Auwaerter, MD, MBA, FIDSA
Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Diseases Johns Hopkins University School of Medicine
Director, Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases Baltimore, MD
Paul G. Auwaerter, MD, MBA, FIDSA
Sherrilyn and Ken Fisher Professor of Medicine

Paul G. Auwaerter is the Sherrilyn and Ken Fisher Professor of Medicine at the Johns Hopkins University School of Medicine serving as the Clinical Director for the Division of Infectious Diseases and Director of the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases.

Dr. Auwaerter serves as the Executive Director of the Johns Hopkins Point of Care-Information Technology (POC-IT) Center producing the Johns Hopkins ABX (Antibiotic), JH HIV, JH Osler, JH Psychiatry, and JH Diabetes Guides. Dr. Auwaerter serves as Editor-in-Chief of the ABX Guide that, over the last 20 years, has grown to be a standard reference for ID-related clinical decision support and rationale for antimicrobial management. His research and clinical interests include improving the diagnosis and care for patients with Lyme disease and other tick-borne infections as well as work in surgical infections, Epstein-Barr virus, respiratory diseases, and antibiotic resistance. He is a Past President of the Infectious Diseases Society of America (IDSA), the largest professional society worldwide related to infectious diseases.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

Each year there are 1 million new cases of shingles in the US, and 1 in 3 adults will develop it in their lifetime. Risk of contracting shingles increases with age, with half of all cases occurring in persons over age 60. Shingles can also lead to complications such as postherpetic neuralgia, blindness, cranial and peripheral nerve palsies, and disseminated infection.

There are currently two approved shingles vaccinations, with the zoster vaccine, recombinant adjuvanted (RZV) being preferred by the Advisory Committee on Immunization Practices (ACIP). Patients are often unaware of the risk imposed by shingles as well as the availability of vaccines. To reduce the profound burden imposed by shingles, it is imperative that clinicians possess the tools needed to successfully implement a shingles protocol in their practice. These tools include identifying at-risk patients, taking advantage of CDC toolkits and checklists, offering strong recommendations for vaccination, and incorporating systems in place to improve vaccine uptake and completion.

This CMEOCast podcast focuses on best practices to increase vaccine uptake and completion in vaccine-eligible patients and those at risk who present to specialty settings. The podcast will address ideal strategies to store and administer RZV, counseling patients on the extensive burden associated with shingles, and the benefits and potential risks of vaccination.

Learning Objectives

At the end of this CME/CE activity, participants should be able to develop best practices to implement a shingles protocol in specialty practice settings.

The following learning objectives pertain only to those requesting CNE or CPE credit: Explain best practices to implement a shingles protocol in specialty practice settings.

Financial Support

This educational activity is supported by an educational grant from GlaxoSmithKline.

Target Audience

Physicians, PAs, nurse practitioners, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: 0376-0000-20-134-H06-P

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Schaffner has no disclosures to report.

Dr. Auwaerter has no disclosures to report.

  • Tony Graham, MD (peer reviewer) has no disclosures to report.
  • Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
  • Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
  • Evan Luberger (planning committee) has no disclosures to report.
  • Jan Perez (planning committee) has no disclosures to report.
  • Sharon Tordoff (planning committee) has no disclosures to report.
  • Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-134-H06-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

 

 

PD-030-091820-08

Implementing a Shingles Protocol in Specialty Practices
Event Date: 09/18/2020